![Micah Mackison](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Micah Mackison
Vorstandsvorsitzender bei Vico Therapeutics BV
Aktive Positionen von Micah Mackison
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Scioto Biosciences, Inc.
![]() Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Direktor/Vorstandsmitglied | - | - |
Vico Therapeutics BV
![]() Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Vorstandsvorsitzender | 01.08.2022 | - |
Karriereverlauf von Micah Mackison
Ehemalige bekannte Positionen von Micah Mackison
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | - | 01.04.2020 |
OVATION Pharmaceuticals, Inc.
![]() OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - | 01.01.2009 |
H. LUNDBECK A/S | Corporate Officer/Principal | - | - |
JABIL INC. | Corporate Officer/Principal | - | - |
Nexhand, Inc. | Gründer | 01.10.2011 | - |
Oakridge Bioventures LLC | Vorstandsvorsitzender | - | - |
Ausbildung von Micah Mackison
Indiana University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Dänemark | 2 |
Niederlande | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
JABIL INC. | Electronic Technology |
H. LUNDBECK A/S | Health Technology |
Private Unternehmen | 5 |
---|---|
OVATION Pharmaceuticals, Inc.
![]() OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Health Technology |
Oakridge Bioventures LLC | |
Nexhand, Inc. | Health Technology |
Scioto Biosciences, Inc.
![]() Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Health Technology |
Vico Therapeutics BV
![]() Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Börse
- Insiders
- Micah Mackison
- Erfahrung